1. Home
  2. EDU vs RGEN Comparison

EDU vs RGEN Comparison

Compare EDU & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo New Oriental Education & Technology Group Inc.

EDU

New Oriental Education & Technology Group Inc.

HOLD

Current Price

$54.92

Market Cap

8.2B

Sector

Real Estate

ML Signal

HOLD

Logo Repligen Corporation

RGEN

Repligen Corporation

HOLD

Current Price

$164.34

Market Cap

8.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EDU
RGEN
Founded
1993
1981
Country
China
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Medical/Dental Instruments
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.2B
8.2B
IPO Year
2006
N/A

Fundamental Metrics

Financial Performance
Metric
EDU
RGEN
Price
$54.92
$164.34
Analyst Decision
Buy
Buy
Analyst Count
6
10
Target Price
$57.87
$174.90
AVG Volume (30 Days)
661.0K
566.0K
Earning Date
01-28-2026
02-19-2026
Dividend Yield
2.18%
N/A
EPS Growth
N/A
N/A
EPS
2.27
0.03
Revenue
$4,987,826,000.00
$707,890,000.00
Revenue This Year
$10.59
$17.84
Revenue Next Year
$10.33
$12.44
P/E Ratio
$24.29
$5,307.14
Revenue Growth
7.29
11.74
52 Week Low
$40.66
$102.97
52 Week High
$64.38
$182.52

Technical Indicators

Market Signals
Indicator
EDU
RGEN
Relative Strength Index (RSI) 52.26 53.89
Support Level $54.15 $161.41
Resistance Level $56.29 $167.65
Average True Range (ATR) 1.08 4.48
MACD 0.11 0.01
Stochastic Oscillator 58.52 68.63

Price Performance

Historical Comparison
EDU
RGEN

About EDU New Oriental Education & Technology Group Inc.

New Oriental Education & Technology is a prominent private education provider in China, offering a wide array of educational services. These include overseas test preparation and consulting services, high school academic tutoring, nonacademic tutoring, and intelligent learning systems and devices. Additionally, the company holds a 57% ownership stake in East Buy, a leading player in the livestreaming e-commerce market.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: